Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region

被引:211
作者
Roesink, JM
Moerland, MA
Battermann, JJ
Hordijk, GJ
Terhaard, CHJ
机构
[1] Univ Utrecht Hosp, Med Ctr, Dept Radiotherapy, NL-3584 CX Utrecht, Netherlands
[2] Univ Utrecht Hosp, Med Ctr, Dept Ear Nose Throat, NL-3584 CX Utrecht, Netherlands
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2001年 / 51卷 / 04期
关键词
parotid gland function; radiation;
D O I
10.1016/S0360-3016(01)01717-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To study the radiation tolerance of the parotid glands as a function of dose and volume irradiated. Methods and Materials: One hundred eight patients treated with primary or postoperative radiotherapy for various malignancies in the head-and-neck region were prospectively evaluated. Stimulated parotid flow rate was measured before radiotherapy and 6 weeks, 6 months, and I year after radiotherapy. Parotid gland dose-volume histograms were derived from CT-based treatment planning. The normal tissue complication probability model proposed by Lyman was fit to the data. A complication was defined as stimulated parotid flow rate < 25% of the preradiotherapy flow rate. Results: The mean stimulated preradiotherapy flow rate of 174 parotid glands was 0.34 mL/min. The mean flow rate reduced to 0.12 mL/min 6 weeks postradiotherapy, but recovered to a mean flow rate of 0.20 mL/min at I year after radiotherapy. Reduction in postradiotherapy flow rate correlated significantly with mean parotid dose. No threshold dose was found. Increasing the irradiated volume of parotid glands from 0%-40% to 90-100% in patients with a mean parotid dose of 35-45 Gy resulted in a decrease in flow ratio from, respectively, approximately 100% to less than 10% 6 weeks after radiation. The flow ratio of the 90%-100% group partially recovered to 15% at 6 months and to 30% at I year after radiotherapy. The normal tissue complication probability model parameter TD50 (the dose to the whole organ leading to a complication probability of 50%) was found to be 31, 35, and 39 Gy at 6 weeks, 6 months, and I year postradiotherapy, respectively. The volume dependency parameter n was around 1, which means that the mean parotid dose correlates best with the observed complications. There was no steep dose-response curve (m = 0.45 at I year post radiotherapy). Conclusions: This study on dose/volume/parotid gland function relationships revealed a linear correlation between postradiotherapy flow ratio and parotid gland dose and a strong volume dependency. No threshold dose was found. Recovery of parotid gland function was shown at 6 months and I year after radiotherapy. In radiation planning, attempts should be made to achieve a mean parotid gland dose at least below 39 Gy (leading to a complication probability of 50%). (C) 2001 Elsevier Science Inc.
引用
收藏
页码:938 / 946
页数:9
相关论文
共 51 条
  • [1] [Anonymous], 1995, Radiother Oncol, V35, P17
  • [2] BACKSTROM I, 1995, ORAL ONCOL, V31B, P253, DOI 10.1016/0964-1955(95)00023-B
  • [3] Modulated beam conformal therapy for head and neck tumors
    Boyer, AL
    Geis, P
    Grant, W
    Carol, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (01): : 227 - 236
  • [4] FITTING OF NORMAL TISSUE TOLERANCE DATA TO AN ANALYTIC-FUNCTION
    BURMAN, C
    KUTCHER, GJ
    EMAMI, B
    GOITEIN, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01): : 123 - 135
  • [5] THE FUNCTION OF THE PAROTID-GLAND FOLLOWING RADIATION-THERAPY FOR HEAD AND NECK-CANCER
    CHENG, VST
    DOWNS, J
    HERBERT, D
    ARAMANY, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1981, 7 (02): : 253 - 258
  • [6] Cox D SE, 1989, ANAL BINARY DATA, P179
  • [7] D'Hondt E, 1998, Spec Care Dentist, V18, P102, DOI 10.1111/j.1754-4505.1998.tb00913.x
  • [9] DAWES C, 1978, J CAN DENT ASSOC, V1, P21
  • [10] A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy
    de Graeff, A
    de Leeuw, JRJ
    Ros, WJG
    Hordijk, GJ
    Blijham, GH
    Winnubst, JAM
    [J]. ORAL ONCOLOGY, 1999, 35 (01): : 27 - 32